Chengdu Kanghua Biological Products (300841) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.026x

Based on the latest financial reports, Chengdu Kanghua Biological Products (300841) has a cash flow conversion efficiency ratio of 0.026x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥92.89 Million ≈ $13.59 Million USD) by net assets (CN¥3.51 Billion ≈ $513.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300841 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Chengdu Kanghua Biological Products - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Chengdu Kanghua Biological Products's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Chengdu Kanghua Biological Products Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chengdu Kanghua Biological Products ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Luzerner Kantonalbank AG LSE:0QNU	0.004x
Shenyang Blue Silver Ind Auto SHE:300293	-0.053x
MAHLE Metal Leve S.A SA:LEVE3	-0.025x
Certara Inc NASDAQ:CERT	0.027x
Shanghai Sunglow Packaging Technology Co Ltd Co Ltd Class A SHG:603499	0.070x
Yatharth Hospital & Trauma Care Services Limited NSE:YATHARTH	0.027x
Revolve Group LLC NYSE:RVLV	0.024x
Xinjiang Beixin Road&Bridge Group Co Ltd SHE:002307	0.022x

Annual Cash Flow Conversion Efficiency for Chengdu Kanghua Biological Products (2015–2024)

The table below shows the annual cash flow conversion efficiency of Chengdu Kanghua Biological Products from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see Chengdu Kanghua Biological Products (300841) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.45 Billion ≈ $504.48 Million	CN¥572.24 Million ≈ $83.74 Million	0.166x	+1.62%
2023-12-31	CN¥3.51 Billion ≈ $514.22 Million	CN¥573.98 Million ≈ $83.99 Million	0.163x	+157.64%
2022-12-31	CN¥3.08 Billion ≈ $450.07 Million	CN¥194.99 Million ≈ $28.53 Million	0.063x	+29.90%
2021-12-31	CN¥2.67 Billion ≈ $390.75 Million	CN¥130.33 Million ≈ $19.07 Million	0.049x	-73.93%
2020-12-31	CN¥1.97 Billion ≈ $288.92 Million	CN¥369.56 Million ≈ $54.08 Million	0.187x	-41.14%
2019-12-31	CN¥574.65 Million ≈ $84.09 Million	CN¥182.73 Million ≈ $26.74 Million	0.318x	+103.86%
2018-12-31	CN¥367.70 Million ≈ $53.81 Million	CN¥57.35 Million ≈ $8.39 Million	0.156x	-67.34%
2017-12-31	CN¥188.37 Million ≈ $27.56 Million	CN¥89.96 Million ≈ $13.16 Million	0.478x	+1838.25%
2016-12-31	CN¥-96.21 Million ≈ $-14.08 Million	CN¥2.64 Million ≈ $386.80K	-0.027x	+56.55%
2015-12-31	CN¥-102.87 Million ≈ $-15.05 Million	CN¥6.51 Million ≈ $951.92K	-0.063x	--

About Chengdu Kanghua Biological Products

SHE:300841 China Biotechnology

Market Cap

$881.17 Million

CN¥6.02 Billion CNY

Market Cap Rank

#9633 Global

#2539 in China

Share Price

CN¥46.34

Change (1 day)

+0.56%

52-Week Range

CN¥44.10 - CN¥92.06

All Time High

CN¥399.08